SP1 and pancreatic neoplasm: For instance, acetate released by CAFs in pancreatic cancer has the capacity to alter polyamine metabolism via the ACSS2-SP1-SAT1 signaling pathway, thereby facilitating the advancement of pancreatic cancer 132.